Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Anxiety and depression are more prevalent in patients with graves' disease than in patients with nodular goitre

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Trends in Costs of Thyroid Disease Treatment in Denmark during 1995-2015

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Treating Hypothyroidism with Thyroxine/Triiodothyronine Combination Therapy in Denmark: Following Guidelines or Following Trends?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Women with coronary microvascular dysfunction and no obstructive coronary artery disease have reduced exercise capacity

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Hippocampal volume, cognitive functions, depression, anxiety, and quality of life in patients with Cushing's syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Thyroid Peroxidase Antibodies and Prospective Live Birth Rate: A Cohort Study of Women with Recurrent Pregnancy Loss

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Age-related renal function decline in Fabry disease patients on enzyme replacement therapy: a longitudinal cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Pro-inflammatory biomarkers in women with non-obstructive angina pectoris and coronary microvascular dysfunction

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND AND OBJECTIVE: Graves' disease has been associated with an increased psychiatric morbidity. It is unclarified whether this relates to Graves' disease or chronic disease per se. The aim of our study was to estimate the prevalence of anxiety and depression symptoms in patients with Graves' disease compared to patients with another chronic thyroid disease, nodular goitre, and to investigate determinants of anxiety and depression in Graves' disease.

METHODS: 157 cross-sectionally sampled patients with Graves' disease, 17 newly diagnosed, 140 treated, and 251 controls with nodular goitre completed the Hospital Anxiety and Depression Scale (HADS). The differences in the mean HADS scores between the groups were analysed using multiple linear regression, controlling for socio-demographic variables. HADS scores were also analysed dichotomized: a score >10 indicating probable 'anxiety'/probable 'depression'. Determinants of anxiety and depression symptoms in Graves' disease were examined using multiple linear regression.

RESULTS: In Graves' disease levels of anxiety (p = 0.008) and depression (p = 0.014) were significantly higher than in controls. The prevalence of depression was 10% in Graves' disease versus 4% in nodular goitre (p = 0.038), anxiety was 18 versus 13% (p = 0.131). Symptoms of anxiety (p = 0.04) and depression (p = 0.01) increased with comorbidity. Anxiety symptoms increased with duration of Graves' disease (p = 0.04). Neither thyroid function nor autoantibody levels were associated with anxiety and depression symptoms.

CONCLUSIONS: Anxiety and depression symptoms were more severe in Graves' disease than in nodular goitre. Symptoms were positively correlated to comorbidity and duration of Graves' disease but neither to thyroid function nor thyroid autoimmunity.

OriginalsprogEngelsk
TidsskriftEuropean Thyroid Journal
Vol/bind3
Udgave nummer3
Sider (fra-til)173-8
Antal sider6
ISSN2235-0640
DOI
StatusUdgivet - sep. 2014

ID: 44891015